2020
DOI: 10.1007/s12185-020-02986-8
|View full text |Cite
|
Sign up to set email alerts
|

Intrapatient variability in concentration/dose ratio of tacrolimus predicts transplant-associated thrombotic microangiopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 35 publications
0
1
0
Order By: Relevance
“…Following surgery, the administration of immunosuppressive medication (received intra-and postoperatively) might also play a role in the development of renal failure. The tacrolimus level from initiation to cessation on D4 due to AKI never exceeded 7 mcg/L, so a microangiopathic cause due to the treatment is highly unlikely, as this tends to occur at levels above 11.4 mcg/L (Table 2) [14]. In this case, renal function was most likely modified by the hemodynamic changes during the procedure, such as the decrease in mean arterial pressure and cardiac output as well as the increase in renal venous pressure.…”
Section: Discussionmentioning
confidence: 99%
“…Following surgery, the administration of immunosuppressive medication (received intra-and postoperatively) might also play a role in the development of renal failure. The tacrolimus level from initiation to cessation on D4 due to AKI never exceeded 7 mcg/L, so a microangiopathic cause due to the treatment is highly unlikely, as this tends to occur at levels above 11.4 mcg/L (Table 2) [14]. In this case, renal function was most likely modified by the hemodynamic changes during the procedure, such as the decrease in mean arterial pressure and cardiac output as well as the increase in renal venous pressure.…”
Section: Discussionmentioning
confidence: 99%